Regulation/NN
of/IN
fas-ligand/NN
expression/NN
during/IN
activation-induced/JJ
cell/NN
death/NN
in/IN
T/NN
lymphocytes/NNS
via/IN
nuclear/JJ
factor/NN
kappaB/NN
./.

T/NN
cell/NN
receptor/NN
engagement/NN
activates/VBZ
transcription/NN
factors/NNS
important/JJ
for/IN
cytokine/NN
gene/NN
regulation/NN
./.
=====
Additionally/RB
,/,
this/DT
signaling/NN
pathway/NN
also/RB
leads/VBZ
to/TO
activation-induced/JJ
apoptosis/NN
in/IN
T/NN
lymphocytes/NNS
that/WDT
is/VBZ
dependent/JJ
on/IN
FasL/NN
transcription/NN
and/CC
expression/NN
./.
=====
Here/RB
we/PRP
demonstrate/VBP
that/IN
nuclear/JJ
factor/NN
kappaB/NN
(/(
NF-kappaB/NN
)/)
,/,
which/WDT
is/VBZ
involved/VBN
in/IN
the/DT
transcriptional/JJ
regulation/NN
of/IN
many/JJ
cytokine/NN
genes/NNS
expressed/VBN
in/IN
activated/VBN
lymphocytes/NNS
,/,
also/RB
plays/VBZ
a/DT
role/NN
in/IN
T/NN
cell/NN
activation-induced/JJ
FasL/NN
expression/NN
./.
=====
Inhibition/NN
of/IN
NF-kappaB/NN
activity/NN
in/IN
a/DT
T/NN
cell/NN
hybridoma/NN
leads/VBZ
to/TO
decreased/VBN
FasL/NN
expression/NN
and/CC
apoptosis/NN
upon/IN
T/NN
cell/NN
receptor/NN
stimulation/NN
./.
=====
We/PRP
identified/VBD
the/DT
NF-kappaB/NN
site/NN
in/IN
the/DT
FasL/NN
promoter/NN
that/WDT
contributes/VBZ
to/TO
such/JJ
regulation/NN
./.
=====
Co-expression/NN
of/IN
p65/NN
(/(
Rel/NN
A/NN
)/)
with/IN
the/DT
FasL/NN
promoter/NN
enhanced/VBD
its/PRP$
activity/NN
,/,
and/CC
co-expression/NN
of/IN
IkappaB/NN
dramatically/RB
inhibited/VBD
the/DT
inducible/JJ
promoter/NN
activity/NN
./.
=====
In/IN
contrast/NN
,/,
the/DT
transcription/NN
factor/NN
AP-1/NN
is/VBZ
not/RB
required/VBN
for/IN
activation-induced/JJ
FasL/NN
promoter/NN
activity/NN
./.
=====
These/DT
results/NNS
define/VBP
a/DT
role/NN
for/IN
NF-kappaB/NN
in/IN
mediating/VBG
FasL/NN
expression/NN
during/IN
T/NN
cell/NN
activation/NN
./.